Authors
Loading...
Randomized trial investigates miR-4443 as a prognostic marker in coronary heart disease, suggesting therapeutic applications.
Sun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: